DJIA 17,678.70 6.10 0.03%
NASDAQ 4,771.76 13.88 0.29%
S&P 500 2,057.09 5.27 0.26%
market minute promo

EXACT Sciences Corp (NASDAQ: EXAS)

27.65 0.49 (1.80%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

EXAS $27.65 1.80%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $27.03
Previous Close $27.16
Daily Range $26.76 - $28.10
52-Week Range $10.69 - $29.97
Market Cap $2.3B
P/E Ratio -26.37
Dividend (Yield) $0.00 (0.0%)
Volume 922,356
Average Daily Volume 1,609,749
Current FY EPS -$1.25

Sector

Healthcare

Industry

Drugs

EXACT Sciences Corp (EXAS) Description

An applied genomics company that develops proprietary DNA-based technologies for use in the detection of cancer. Website: http://www.exactsciences.com/

News & Commentary

Could This Common Medicine Cabinet Supplement Be the Key to Increased Survival for Some Cancer Patie

Is it really this simple? Could this medicine cabinet supplement really improve the average survival of advanced cancer patients? A new study might suggest so.

Exact Sciences' Puzzling Early Launch Trajectory Update For Cologuard - An Analysis

The Liquid Biopsy Will Boost Revenue For Sequenom And Illumina

Why You Shouldn't Bet Against Exact Sciences (EXAS) Stock - Tale of the Tape

Big Short Interest On These 5 Biotech Stocks

Why Shares of Foundation Medicine, Inc. Skyrocketed Today

Shares of cancer diagnostic maker Foundation Medicine more than doubled Monday morning. Here's why.

In Case You Missed it, This New Cancer Study is Terrifying

A terrifying new cancer study out of Johns Hopkins Medicine confirms a suspicion some researchers have harbored all along.

UPDATE: Lake Street Initiates Coverage On EXACT Sciences

Health Care Sector Update for 12/22/2014: EXAS,NVLX,GILD,ESRX,ABBV

Monday's #PreMarket Movers: Caesars, Enta, Twitter And More

See More EXAS News...

EXAS's Top Competitors

EXAS $27.65 (1.80%)
Current stock: EXAS
AMGN $159.73 (-0.05%)
Current stock: AMGN
GILD $107.12 (1.50%)
Current stock: GILD
BIIB $362.44 (1.37%)
Current stock: BIIB